Bank of Montreal’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,625
Closed -$44K 5458
2021
Q1
$44K Sell
2,625
-7,922
-75% -$180K ﹤0.01% 3767
2020
Q4
$227K Buy
10,547
+7,382
+233% +$132K ﹤0.01% 3160
2020
Q3
$45K Sell
3,165
-885
-22% -$13.6K ﹤0.01% 3488
2020
Q2
$70K Buy
+4,050
New +$61.1K ﹤0.01% 3264
2020
Q1
Sell
-4,971
Closed -$41K 4986
2019
Q4
$41K Buy
4,971
+1,795
+57% +$16.6K ﹤0.01% 3949
2019
Q3
$32K Buy
3,176
+701
+28% +$6.62K ﹤0.01% 3839
2019
Q2
$31K Buy
+2,475
New +$26.1K ﹤0.01% 3924
2019
Q1
Sell
-140
Closed -$1K 4950
2018
Q4
$1K Buy
140
+72
+106% +$527 ﹤0.01% 4598
2018
Q3
$1K Buy
+68
New +$792 ﹤0.01% 4657

Other funds holding TBIO

Bank of Montreal's TBIO Position: Q2 2021 in Review

Bank of Montreal sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 2,625 shares — an estimated $44K sold.

Bank of Montreal first reported a position in TBIO in Q3 2018 and held it in 9 quarters. The position peaked at $227K in Q4 2020. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Bank of Montreal reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,625 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $44K.
  • Bank of Montreal first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
  • Bank of Montreal's Translate Bio, Inc. Common Stock position peaked at $227K in Q4 2020.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.